LOAN AND SECURITY AGREEMENT Dated as of January 8, 2024 between ABEONA THERAPEUTICS INC., a Delaware corporation (“Company”), MACROCHEM CORPORATION, a Delaware corporation (“Macrochem”), as a borrower ABEONA THERAPEUTICS LLC, an Ohio limited liability...Loan and Security Agreement • January 8th, 2024 • Abeona Therapeutics Inc. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 8th, 2024 Company Industry JurisdictionBorrower, Lenders and Agent anticipate entering into one or more transactions pursuant to which each Lender agrees to make available to Borrower a loan facility governed by the terms and conditions set forth in this document and one or more Supplements executed by Borrower, Lenders and Agent which incorporate this document by reference. Each Supplement constitutes a supplement to and forms part of this document, and will be read and construed as one with this document, so that this document and the Supplement constitute a single agreement between the parties (collectively referred to as this “Agreement”).
LOAN AND SECURITY AGREEMENT Dated as of November 22, 2022 between EYENOVIA, INC., a Delaware corporation, as “Borrower”, and AVENUE CAPITAL MANAGEMENT II, L.P., a Delaware limited partnership, as administrative agent and collateral agent (in such...Loan and Security Agreement • March 31st, 2023 • Eyenovia, Inc. • Pharmaceutical preparations • California
Contract Type FiledMarch 31st, 2023 Company Industry JurisdictionBorrower, Lenders and Agent have entered or anticipate entering into one or more transactions pursuant to which each Lender agrees to make available to Borrower a loan facility governed by the terms and conditions set forth in this document and one or more Supplements executed by Borrower, Lenders and Agent which incorporate this document by reference. Each Supplement constitutes a supplement to and forms part of this document, and will be read and construed as one with this document, so that this document and the Supplement constitute a single agreement between the parties (collectively referred to as this “Agreement”).
LOAN AND SECURITY AGREEMENT Dated as of March 21, 2023 between LIFEMD, INC., a Delaware corporation as “Borrower”, and AVENUE VENTURE OPPORTUNITIES FUND II, L.P., a Delaware limited partnership, (“Avenue 2”), as a lender, andLoan and Security Agreement • March 23rd, 2023 • LifeMD, Inc. • Services-offices & clinics of doctors of medicine • California
Contract Type FiledMarch 23rd, 2023 Company Industry JurisdictionBorrower, Lenders and Agent anticipate entering into one or more transactions pursuant to which each Lender agrees to make available to Borrower a loan facility governed by the terms and conditions set forth in this document and one or more Supplements executed by Borrower, Lenders and Agent which incorporate this document by reference. Each Supplement constitutes a supplement to and forms part of this document, and will be read and construed as one with this document, so that this document and the Supplement constitute a single agreement between the parties (collectively referred to as this “Agreement”).
LOAN AND SECURITY AGREEMENT Dated as of June 3, 2022 between ORCHESTRA BIOMED, INC., a Delaware corporation, as “Borrower”, andLoan and Security Agreement • September 23rd, 2022 • Health Sciences Acquisitions Corp 2 • Surgical & medical instruments & apparatus • New York
Contract Type FiledSeptember 23rd, 2022 Company Industry JurisdictionBorrower, Lenders and Agent have entered into this Loan and Security Agreement pursuant to which each Lender agrees to make available to Borrower a loan facility governed by the terms and conditions set forth in this document and the Supplement executed by Borrower, Lenders and Agent which incorporate this document by reference. The Supplement constitutes a supplement to and forms part of this document and will be read and construed as one with this document, so that this document and the Supplement constitute a single agreement between the parties (collectively referred to as this “Agreement”).
LOAN AND SECURITY AGREEMENT Dated as of November 30, 2021 between BIOVIE INC. a Nevada corporation, as “Borrower”, and AVENUE VENTURE OPPORTUNITIES FUND II, L.P., a Delaware limited partnership (“AVOF 2”), as a lender and AVENUE VENTURE OPPORTUNITIES...Loan and Security Agreement • December 1st, 2021 • Biovie Inc. • Pharmaceutical preparations • California
Contract Type FiledDecember 1st, 2021 Company Industry JurisdictionThis Loan and Security Agreement dated as of November 30, 2021 is by and between Borrower (as defined in the Supplement (as defined below)), Agent (as defined in the Supplement (as defined below)) and Lender (as defined in the Supplement (as defined below)) (as amended, amended and restated, supplemented, or otherwise modified from time to time, the “Loan Agreement”) pursuant to which Lender agrees to make available to Borrower a loan facility governed by the terms and conditions set forth in this Loan Agreement and one or more Supplements executed by Borrower and Lender which incorporate this Loan Agreement by reference. Each Supplement constitutes a supplement to and forms part of this Loan Agreement, and will be read and construed as one with this Loan Agreement, so that this Loan Agreement and any Supplement constitute a single agreement between the parties (this Loan Agreement and the Supplement, each as amended, amended and restated, supplemented, or otherwise modified from time